Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/137796
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCastro, J.-
dc.contributor.authorMaddern, J.-
dc.contributor.authorGarcia-Caraballo, S.-
dc.contributor.authorSchober, G.-
dc.contributor.authorLindstrom, B.-
dc.contributor.authorSchmiel, S.-
dc.contributor.authorBrierley, S.M.-
dc.date.issued2020-
dc.identifier.citationNeurogastroenterology and Motility, 2020, vol.32, iss.Suppl. 1, pp.e13817-86-e13817-86-
dc.identifier.issn1350-1925-
dc.identifier.issn1365-2982-
dc.identifier.urihttps://hdl.handle.net/2440/137796-
dc.descriptionPoster presentation 222-
dc.description.statementofresponsibilityJoel Castro, Jessica Maddern, Sonia Garcia-Caraballo, Gudrun Schober, Beatriz Lindstrom, Shirdi Schmiel, Stuart M. Brierley-
dc.language.isoen-
dc.publisherWiley-
dc.rights© 2020 The Authors. Neurogastroenterology & Motility © 2020 John Wiley & Sons Ltd-
dc.source.urihttps://onlinelibrary.wiley.com/toc/13652982/2020/32/S1-
dc.titleOlorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2 (CB2), reduces visceral hypersensitivity in mice-
dc.typeConference item-
dc.contributor.conference4th Meeting of the Federation of Neurogastroenterology and Motility (FNM) (25 Mar 2020 - 28 Mar 2020 : Adelaide Convention Centre, Adelaide, Australia)-
dc.identifier.doi10.1111/nmo.13817-
pubs.publication-statusPublished-
dc.identifier.orcidBrierley, S.M. [0000-0002-2527-2905]-
Appears in Collections:Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.